Successful Re-treatment of Hepatitis C Virus in Patients Coinfected With HIV Who Relapsed After 12 Weeks of Ledipasvir/Sofosbuvir

We assessed the efficacy and safety of ledipasvir/sofosbuvir plus ribavirin for 24 weeks in 9 human immunodeficiency virus/hepatitis C virus–coinfected patients who relapsed after receiving 12 weeks of treatment with ledipasvir/sofosbuvir. Eight of 9 (89%) achieved sustained virologic response 12 we...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:Clin Infect Dis
Autori principali: Cooper, Curtis, Naggie, Susanna, Saag, Michael, Yang, Jenny C., Stamm, Luisa M., Dvory-Sobol, Hadas, Han, LingLing, Pang, Phillip S., McHutchison, John G., Dieterich, Douglas, Sulkowski, Mark
Natura: Artigo
Lingua:Inglês
Pubblicazione: Oxford University Press 2016
Soggetti:
Brief Reports
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC4967607/
https://ncbi.nlm.nih.gov/pubmed/27225242
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/cid/ciw349
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi